Journal Home
Search for

Volume 138, Issue 3, Pages 733-737 (September 2009)


View previous. 37 of 80 View next.

Percutaneous reimplantation of a pulmonary valved stent in sheep: A potential treatment for bioprosthetic valve degeneration

Yuan Bai, MDa, Gang-Jun Zong, MDc, Hai-Bing Jiang, MDa, Wei-Ping Li, MDb, Hong Wu, MDa, Xian-Xian Zhao, MDa, Yong-Wen Qin, MDaCorresponding Author Informationemail address

Received 19 February 2009; received in revised form 24 April 2009; accepted 18 May 2009. published online 29 June 2009.

Objective

Percutaneous pulmonary valve replacement has been recently introduced into clinical practice. Patients with transcatheter pulmonary valve replacement will definitely face the problems of valve degeneration. In addition to surgical re-replacement of the degenerated bioprosthetic valves, we studied the replacement of degenerated bioprosthetic valves with transcatheter reimplantation of stent-mounted pulmonary valves.

Methods

Percutaneous pulmonary valve replacement was first performed in 6 sheep used a homemade valved stent. Two months after the initial procedure, the 6 sheep previously implanted with a valved stent underwent the same implantation procedure of a pulmonary valved stent. Hemodynamic assessment of the bioprosthetic pulmonary valve was obtained by echocardiography immediately post-implant and at 2 months follow-up.

Results

All 6 sheep had successful transcatheter stent-mounted pulmonary valve replacement in the first experiment. After 2 months, reimplantation was successful in 5 sheep but failed in 1 sheep because the first valved stent was pushed to the bifurcation of the pulmonary artery by the delivery sheath. Echocardiography confirmed the stents were in the desired position during the follow-up. The remaining 5 sheep with normal valvular and cardiac functionality survived for 3 months after implantation.

Conclusion

Transcatheter stent-mounted bioprosthetic pulmonary valve reimplantation is feasible in an animal model and more convenient than open chest reimplantation.

CTSNet classification35

a Department of Cardiology, Changhai Hospital, the Second Military Medical University, Shanghai, China

b Department of Ultrasonography, Changhai Hospital, the Second Military Medical University, Shanghai, China

c Department of Cardiology, 101 Hospital of PLA, Wuxi, Jiangsu Province, China

Corresponding Author InformationAddress for reprints: Yong-Wen Qin, MD, Department of Cardiology, Changhai Hospital, The Second Military Medical University, Shanghai, 200433, China.

 Y. Bai and G.-J. Zong contributed equally to this study.

 This study was supported by National High-Tech R and D Program of China (“863” Program) (2006AA02Z4D7).

 Disclosures: There is no conflict of interest in this study.

PII: S0022-5223(09)00759-4

doi:10.1016/j.jtcvs.2009.05.023


View previous. 37 of 80 View next.